Get the Stockscreener App
1.49
2.76%
0.04
After Hours:
1.42
-0.07
-4.70%
Prf Technologies Ltd stock is traded at $1.49, with a volume of 113.35K.
It is up +2.76% in the last 24 hours and down -40.16% over the past month.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
See More
Previous Close:
$1.45
Open:
$1.37
24h Volume:
113.35K
Relative Volume:
0.23
Market Cap:
$1.29M
Revenue:
-
Net Income/Loss:
$-5.02M
P/E Ratio:
-0.1755
EPS:
-8.4895
Net Cash Flow:
$-3.96M
1W Performance:
-5.70%
1M Performance:
-40.16%
6M Performance:
-65.55%
1Y Performance:
-84.72%
1-Day Range:
$1.34
$1.53
1-Week Range:
$1.28
$1.61
52-Week Range:
$1.28
$17.95
Prf Technologies Ltd Stock (PRFX) Company Profile
Compare PRFX vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRFX
Prf Technologies Ltd
|
1.49 | 1.26M | 0 | -5.02M | -3.96M | -8.4895 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Prf Technologies Ltd Stock (PRFX) Latest News
PRFX Q2 2024 Earnings: EPS Misses Estimates as Company Continues Development StageEarnings Revision Upgrade - Newser
$PRF Technologies (PRFX.US)$ Blacklist this lousy stock - Moomoo
[EFFECT] PRF Technologies Ltd. SEC Filing - Stock Titan
PRF Technologies (PRFX) registers 3,000,000 shares; $10M equity facility - Stock Titan
PRFX: Share Offering by Selling Stockholder Announced - GuruFocus
PRF Technologies (PRFX) registers 3.0M shares for resale under equity line - Stock Titan
YA II PN's 9.99% PRFX position and $10M SEPA with PRF Technologies (PRFX) - Stock Titan
PRF Technologies Secures Up to $10 Million Standby Equity Facility With Yorkville - The Globe and Mail
What PRF Technologies (PRFX) is doing that smarter investors notice (-0.52%) 2026-05-07Stock Picks - Newser
PRF Technologies (NASDAQ: PRFX) inks $10M standby equity deal with Yorkville - Stock Titan
EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery Pain - Yahoo Finance
PRF Technologies Wins FDA IND Clearance for OcuRing-K Phase II Cataract Trial - The Globe and Mail
FDA clears PRF Technologies’ IND for cataract surgery treatment - Investing.com UK
FDA clears PRF Technologies’ IND for cataract surgery treatment By Investing.com - Investing.com South Africa
PRFX Receives FDA Clearance for OcuRing-K Clinical Trials - GuruFocus
FDA clears PRF Technologies (PRFX) IND for OcuRing-K Phase II eye trial - Stock Titan
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial - The Manila Times
PRF Technologies Ltd. Announces FDA Clearance Of IND Application For OcuRing-K Phase II Clinical Trial - marketscreener.com
PRF Technologies Ltd. Ordinary Shares (PRFX) posts far wider Q1 2024 loss than analyst estimates, sending its shares down 2.18% today.Customer Loyalty - Cổng thông tin điện tử tỉnh Tây Ninh
PRFX (PRF Technologies Ltd. Ordinary Shares) reports far wider Q1 2024 loss than estimates, shares dip modestly today.Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Tây Ninh
PRF Technologies (PRFX) Stock Manual Trade (Momentum Fading) 2026-04-20Trending Stock Ideas - Newser
Ellen S Baron Net Worth (2026) - GuruFocus
Sigal Aviel Net Worth (2026) - GuruFocus
Ehud Geller Net Worth (2026) - GuruFocus
Eyal Broder Net Worth (2026) - GuruFocus
Efraim Cohen Arazi Net Worth (2026) - GuruFocus
Asaf Shavit Net Worth (2026) - GuruFocus
PRF Technologies (PRFX) Stock: Valuation Perspective (-2.18%) 2026-04-15Expert Breakout Alerts - UBND thành phố Hải Phòng
What's Going On With Pharma Company PRF Technologies On Tuesday? - Sahm
Morning Market Movers: ADVB, SKYQ, FCUV, KPRX See Big Swings - RTTNews
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
12 Health Care Stocks Moving In Monday's Intraday SessionABVC BioPharma (NASDAQ:ABVC), Aditxt (NASDAQ - Benzinga
PRF Technologies Sees Strategic Growth with DeepSolar Expansion - StocksToTrade
PRF Technologies Expands Global Solar Reach: Strategic Partnership with Blade Ranger - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
$PRF Technologies (PRFX.US)$ 🫡 out .91 - Moomoo
Is PRF Technologies (PRFX) Stock Breaking Resistance | Price at $2.63, Up 25.24%Investment Factor - Newser
PRFX PE Ratio & Valuation, Is PRFX Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
PRFX SEC FilingsPRF Technologies Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
PRFX Should I Buy - Intellectia AI
PRF Technologies Posts 2025 Results as LayerBio and DeepSolar Deals Drive Dual-Platform Pivot - The Globe and Mail
PRF Technologies reports 2025 results, advances drug delivery platform By Investing.com - Investing.com Australia
PRF Technologies reports 2025 results, advances drug delivery platform - Investing.com
[6-K] PRF Technologies Ltd. Current Report (Foreign Issuer) | PRFX SEC FilingForm 6-K - Stock Titan
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across ... - Bluefield Daily Telegraph
PRF Technologies Provides Year-End 2025 Business Update - GlobeNewswire
PRF Technologies (NASDAQ: PRFX) 20-F details going concern risk and cash needs - Stock Titan
Prf Technologies Ltd Stock (PRFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):